Insider Selling: Haleon plc (LON:HLN) Insider Sells £277,805.88 in Stock

Haleon plc (LON:HLN) insider Dawn Allen sold 74,679 shares of the stock in a transaction on Thursday, November 21st. The stock was sold at an average price of GBX 372 ($4.68), for a total value of £277,805.88 ($349,837.40).

Haleon Price Performance

Shares of LON:HLN opened at GBX 379.72 ($4.78) on Monday. The firm has a market cap of £34.33 billion, a price-to-earnings ratio of 3,169.17, a P/E/G ratio of 1.49 and a beta of 0.19. The firm has a fifty day moving average price of GBX 379.25 and a 200 day moving average price of GBX 357.45. Haleon plc has a fifty-two week low of GBX 308.37 ($3.88) and a fifty-two week high of GBX 400.65 ($5.05). The company has a debt-to-equity ratio of 54.18, a quick ratio of 0.93 and a current ratio of 0.84.

Analysts Set New Price Targets

Separately, Berenberg Bank increased their target price on Haleon from GBX 410 ($5.16) to GBX 447 ($5.63) and gave the stock a “buy” rating in a research report on Monday, August 5th.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.